Peer review reports
From: Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
Original Submission | ||
---|---|---|
7 Nov 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
12 Mar 2023 | Reviewed | Reviewer Report |
22 Mar 2023 | Reviewed | Reviewer Report |
5 Apr 2023 | Author responded | Author comments - Kyungmoo Yea |
Resubmission - Version 4 | ||
5 Apr 2023 | Submitted | Manuscript version 4 |
10 Apr 2023 | Author responded | Author comments - Kyungmoo Yea |
Resubmission - Version 5 | ||
10 Apr 2023 | Submitted | Manuscript version 5 |
4 May 2023 | Reviewed | Reviewer Report |
15 May 2023 | Reviewed | Reviewer Report |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Publishing | ||
16 May 2023 | Editorially accepted | |
31 May 2023 | Article published | 10.1186/s12885-023-10975-3 |